Across TCGA pan-cancer cohorts, RNU6-730P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNU6-730P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-730P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-730P expression acts as an unfavorable survival marker.

OV, KICH, and CESC are the cancer types where RNU6-730P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.278	0.843	<.001	108	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
CESC	OS	Tertile	II,III,IV	0.156	0.759	.007	78	view →
BLCA	DFS	Tertile	All	0.118	0.627	<.001	72	view →
LUAD	DFS	Tertile	All	0.484	0.822	<.001	66	view →
ESCA	OS	Tertile	III,IV	0.124	0.574	.004	36	view →
STAD	OS	Tertile	IV	0.111	0.433	.002	33	view →
KIRP	OS	Tertile	II,III,IV	0.180	0.771	.007	27	view →
LUSC	OS	Tertile	All	0.244	0.660	.025	27	view →
ACC	OS	Tertile	All	0.118	0.624	.038	18	view →
SKCM	OS	Tertile	III,IV	0.290	0.737	<.001	18	view →
KIRC	DFS	Tertile	IV	0.216	0.623	.035	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

Exploration

Same gene, other analysis: RNU6-730P tumor-vs-normal RNA expression · all RNU6-730P data types